Show simple item record

dc.contributor.authorBerekméri, Anna
dc.contributor.authorLatzko, Anne
dc.contributor.authorAlase, Adewonuola
dc.contributor.authorMacleod, Tom
dc.contributor.authorAinscough, Joseph S
dc.contributor.authorLaws, Philip
dc.contributor.authorGoodfield, Mark
dc.contributor.authorWright, Andrew
dc.contributor.authorHelliwell, Philip
dc.contributor.authorEdward, Sara
dc.contributor.authorBrown, Gordon D
dc.contributor.authorReid, Delyth M
dc.contributor.authorWenzel, Joerg
dc.contributor.authorStacey, Martin
dc.contributor.authorWittmann, Miriam
dc.date.accessioned2018-08-02T08:32:06Z
dc.date.available2018-08-02T08:32:06Z
dc.date.issued2018-09
dc.identifier.citationBerekméri , A , Latzko , A , Alase , A , Macleod , T , Ainscough , J S , Laws , P , Goodfield , M , Wright , A , Helliwell , P , Edward , S , Brown , G D , Reid , D M , Wenzel , J , Stacey , M & Wittmann , M 2018 , ' Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema ' Journal of Allergy and Clinical Immunology , vol. 142 , no. 3 , pp. 988-991 . DOI: 10.1016/j.jaci.2018.04.031en
dc.identifier.issn0091-6749
dc.identifier.otherPURE: 118170053
dc.identifier.otherPURE UUID: 678c2f9e-ce76-4ae6-965d-b608a4e4ba3c
dc.identifier.otherPubMed: 29782895
dc.identifier.otherPubMed: 29782895
dc.identifier.otherScopus: 85049315769
dc.identifier.urihttp://hdl.handle.net/2164/10849
dc.descriptionThis project was mainly supported by a 2014 Pfizer Inflammation Competitive Research Programme (ICRP). In addition, assay development support was received by MRC grant MR/M01942X/1. GDB and DMR were funded by the Wellcome Trust (102705, 97377), the MRC Centre for Medical Mycology and the University of Aberdeen (MR/N006364/1). Some of the samples included in the atopic dermatitis comparator group were acquired in the context of the National Institute for Health Research (NIHR) funded ALPHA trial (EUDRACT 2014-004741-27) – explorative biomarker substudy. The ALPHA trial was developed in collaboration with the Clinical Trials Research Unit at the University of Leeds with support from the UK Dermatology Clinical Trials Network (UK DCTN). The UK DCTN is grateful to the British Association of Dermatologists and the University of Nottingham for financial support of the Network. This research is also supported by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.en
dc.format.extent4en
dc.language.isoeng
dc.relation.ispartofJournal of Allergy and Clinical Immunologyen
dc.rightsThis is an open access articleunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).en
dc.subjectPsoriasisen
dc.subjectAtopic Dermatitisen
dc.subjectEczemaen
dc.subjectIL-36en
dc.subjectDiagnosticen
dc.subjectbiomarkeren
dc.subjectR Medicine (General)en
dc.subjectQR180 Immunologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/M01942X/1en
dc.subjectMR/N006364/1en
dc.subjectWellcome Trusten
dc.subject102705en
dc.subject97377en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject2014-004741-27en
dc.subject.lccR1en
dc.subject.lccQR180en
dc.titleDetection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczemaen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen, Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen, MRC Centre for Medical Mycologyen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.jaci.2018.04.031


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record